Leukapheresis Device Industry Forecast to Hit $0.94 Billion by 2029 With a Strong 7.5% CAGR

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Leukapheresis Device Market Covering 2025–2034?

The leukapheresis device market has experienced significant expansion recently. It is projected to increase from $0.65 billion in 2024 to $0.70 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.7%. The market’s past growth can be ascribed to factors such as the burgeoning demand for personalized medicine, a stronger focus on research and development, a rising volume of clinical trials, the expanding geriatric population, and the growing adoption of minimally invasive procedures.

The leukapheresis device market is set for significant expansion in the coming years. It is forecast to climb to $0.94 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.5%. This growth projection for the forecast period is fueled by several factors, including the rising incidence of blood-related disorders, an increasing number of cancer cases, a growing necessity for peripheral blood stem cell collection, the expanding application of leukapheresis in cellular therapies, and elevated investments in regenerative medicine and immunotherapy. Noteworthy trends during this period are expected to include technological progress in apheresis devices, the incorporation of automation and digital interfaces, advancements in point-of-care leukapheresis technology, improvements in closed-loop leukapheresis systems, and efficiency enhancements in cell separation driven by technology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp

Which Drivers Are Shaping The Leukapheresis Device Industry’s Market Share?

The increasing occurrence of blood-related conditions is anticipated to fuel the expansion of the leukapheresis device market moving forward. These disorders involve issues affecting the structure or function of blood cells, leading to difficulties with oxygen transport, immune responses, or blood coagulation. The growing number of blood-related illnesses is mainly linked to an aging population, as older individuals face a higher risk of developing conditions like anemia, leukemia, and various hematological problems. Leukapheresis devices aid in managing these ailments by specifically removing excess or abnormal white blood cells from the bloodstream, thus helping to ease symptoms and lessen complications in diseases such as leukemia and autoimmune conditions. For example, in May 2024, data from the Leukaemia Foundation, an Australia-based non-profit organization, indicated that in 2022, approximately 19,403 Australians received diagnoses for blood cancers, including leukemia, lymphoma, or myeloma, averaging 53 cases daily, or one every 27 minutes. Currently, close to 135,000 Australians are living with a blood cancer or blood disorder, a figure expected to exceed 275,000 by 2035. Consequently, the increasing occurrence of blood-related disorders is propelling the expansion of the leukapheresis device market.

What Are The Leading Segments Analyzed In The Leukapheresis Device Market?

The leukapheresis device market covered in this report is segmented –

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices

2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters

3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers

Subsegments:

1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices

2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems

3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems

4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices

5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators

6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags

7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

How Are Emerging Market Trends Shaping The Leukapheresis Device Industry Landscape?

Major companies engaged in the leukapheresis device market are concentrating on developing regional manufacturing infrastructure to improve local access to advanced therapeutic devices and support country-specific healthcare goals. These regional manufacturing investments aid in establishing robust and flexible supply chains, which ensures timely product availability, reduces reliance on foreign imports, and makes sophisticated blood and cell collection systems more accessible financially. As an illustration, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology firm, joined forces with its Chinese medical technology subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to inaugurate localized manufacturing operations in Hangzhou, China. This key strategic action involves the domestic production of essential leukapheresis products such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both of which are widely employed across China for therapeutic apheresis, stem cell collection, and the separation of blood components.

Which Key Market Players Are Investing In Expansion And Innovation Of Leukapheresis Device Market?

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Charles River Laboratories International Inc., Mallinckrodt Pharmaceuticals, Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, Precision for Medicine Inc., B. Braun Melsungen AG, BioIVT LLC, AllCells LLC, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd., Puriblood Medical Co. Ltd, Medica S.p.A.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Which Regional Markets Are Contributing Most To The Leukapheresis Device Industry Expansion?

North America was the largest region in the leukapheresis device market in 2024. The regions covered in the leukapheresis device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Leukapheresis Device Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25807&type=smp

Browse Through More Reports Similar to the Global Leukapheresis Device Market 2025, By The Business Research Company

Oncology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Interventional Oncology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Nephrostomy Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nephrostomy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795